A Note on Safety and Individualization Not every woman is a candidate for HRT, and not every woman needs a GLP-1 medication
It operates by mimicking the functions of the human glucagon-like peptide-1 (GLP-1), thereby enhancing insulin secretion, inhibiting glucagon release, and ultimately leading to improved glycemic control and weight loss
Still, they are relevant when the controlled safety evidence is sparse
For instance, a clinical trial of 11,000 people found that using GLP-1 RAs reduced kidney disease progression by 18%, kidney failure by 16% and risk of cardiac events by 13%
CJC-1295 is a modified peptide that mimics growth-hormone-releasing-hormone to secrete growth hormone that doesnt broken down as quickly as synthetic GH
The federal government wont be helping anytime soon, either